| Financial Year |
March 31 2023 |
| Monetary Funds |
859,302,859.94 |
| Held-for-trading Financial Assets |
532,220,964.78 |
| Notes Receivable |
342,309,930.78 |
| Accounts Receivable |
708,772,677.13 |
| Advances to Suppliers |
53,997,795.56 |
| Other Receivables |
33,711,929.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,001,985.87 |
| Dividend Receivable |
-- |
| Inventories |
154,195,259.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,929,272.59 |
| Total Current Assets |
3,205,542,573.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,548,944.71 |
| Investment Properties |
-- |
| Fixed Assetes |
1,240,066,592.16 |
| Under-construction Projects |
292,158,502.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,287,252.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,056,834.70 |
| Deferred Income Tax Assets |
62,622,966.69 |
| Other Non-Current Assets |
52,887,583.27 |
| Sub-Total of Non-Current Assets |
2,043,264,660.08 |
| Total Assets |
5,248,807,233.41 |
| Short-Term Loans |
499,440,753.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
351,058,538.71 |
| Accounts Payable |
530,234,038.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
535,180.46 |
| Taxes Payable |
10,585,610.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,594,795.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,995,966.68 |
| Other Current Liabilities |
4,529,785.26 |
| Sub-Total of Current Liabilities |
1,485,694,836.44 |
| Long-term Loans |
297,659,543.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,601,674.11 |
| Deferred Income Tax Liabilities |
16,971,602.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
497,897,225.11 |
| Total Liabilities |
1,983,592,061.55 |
| Paid-In Capital(Or Share Stock) |
199,062,500.00 |
| Capital Surplus |
2,432,013,152.45 |
| Surplus Reserve |
87,140,577.98 |
| LESS:Treasury Stock |
133,762,437.36 |
| Undistributed Profits |
661,711,501.32 |
| Minority Stockholder's Interest |
22,741,017.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,242,474,154.28 |
| Owner's Equity（Stockholder's Equity） |
3,265,215,171.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,248,807,233.41 |
